Author:
Baselga José,Swain Sandra M.
Reference18 articles.
1. Extending survival with chemotherapy in metastatic breast cancer;O’Shaughnessy;Oncologist,2005
2. Breast cancer: New developments in the treatment of metastatic breast cancer: from chemotherapy to biological therapy;Mariani;Ann Oncol,2005
3. Two concurrent phase II trials of paclitaxel/carboplatin/trastuzumab (weekly or every-3-week schedule) as first-line therapy in women with HER2-overexpressing metastatic breast cancer: NCCTG study 983252;Perez;Clin Breast Cancer,2005
4. Superior long-term survival benefits of trastuzumab plus docetaxel compared to docetaxel alone in patients with HER2-positive metastatic breast cancer: patients surviving more than 4 years in the M77001 study;Marty;Breast Cancer Res Treat,2006
5. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987
Cited by
114 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献